- Presentations
- 7
- Markets
- 1
Lamictal XR is a brand of Lamotrigine marketed by GlaxoSmithKline, with 7 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Lamotrigine
- Brand owner
- GlaxoSmithKline
- Registered in
- United States
- Strengths and forms
- 100 mg extended-release tablet, 200 mg extended-release tablet, 25 mg extended-release tablet, 250 mg extended-release tablet, 300 mg extended-release tablet, 50 mg extended-release tablet, kit
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Lamictal XR 100 mg extended-release tabletOral | GlaxoSmithKline | US FDA | Available on request |
| Lamictal XR 200 mg extended-release tabletOral | GlaxoSmithKline | US FDA | Available on request |
| Lamictal XR 25 mg extended-release tabletOral | GlaxoSmithKline | US FDA | Available on request |
| Lamictal XR 250 mg extended-release tabletOral | GlaxoSmithKline | US FDA | Available on request |
| Lamictal XR 300 mg extended-release tabletOral | GlaxoSmithKline | US FDA | Available on request |
| Lamictal XR 50 mg extended-release tabletOral | GlaxoSmithKline | US FDA | Available on request |
| Lamictal XR kit | GlaxoSmithKline | US FDA | Available on request |
Equivalent brands
Other brands of Lamotrigine.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Lamictal XR
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.